Mumbai, Oct. 23 -- The newly formed entity aims to expand Aurobindo Pharma's pharmaceutical products business in Chile. The company stated that no governmental or regulatory approvals were required for the incorporation.

The subsidiary has been incorporated with an initial share capital of CLP 1,000,000 (approximately USD 1,050), divided into 100 shares with a nominal value of CLP 10,000 each. Eugia Pharma B.V. has subscribed to 100% of the share capital in cash, thereby holding full ownership of the Chilean entity.

Aurobindo Pharma is principally engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services.

The company's consolidated net profit tumbled 10.3% to Rs 824.7...